Albert Sabin

Albert Sabin. He was a Polish-American medical researcher best known for developing the oral, live-attenuated vaccine against poliomyelitis, which became the global standard for eradicating the disease. His work, conducted primarily at the University of Cincinnati College of Medicine and the Children's Hospital Research Foundation, stood in contrast to the earlier inactivated vaccine created by Jonas Salk. Sabin's vaccine was easier to administer and provided longer-lasting immunity, playing a decisive role in global public health campaigns led by organizations like the World Health Organization.

Early life and education

Born in Białystok, then part of the Russian Empire, he immigrated with his family to the United States in 1921 to escape pogroms. Settling in Paterson, New Jersey, he learned English quickly and developed an interest in medicine. He earned his undergraduate degree from New York University in 1928 and his medical degree from the New York University School of Medicine in 1931. His early research interests in infectious disease were shaped during his internship at Bellevue Hospital and his work at the Lister Institute of Preventive Medicine in London.

Medical career and research

After completing his medical training, he began his research career at the Rockefeller Institute for Medical Research, studying poliovirus and other viruses like dengue fever. During World War II, he served as a major in the United States Army Medical Corps, where he developed vaccines for dengue fever and Japanese encephalitis that protected troops in the Pacific Theater. After the war, he became a professor of research pediatrics at the University of Cincinnati College of Medicine and continued his intensive study of poliovirus, focusing on its behavior in the human gastrointestinal tract.

Development of the oral polio vaccine

His pivotal research demonstrated that poliovirus entered the body through the digestive system, which led him to champion a live-attenuated oral vaccine. He attenuated strains of the virus by passing them through non-human tissue, such as in monkey kidney cells. After extensive clinical trials in the late 1950s, including massive tests in the Soviet Union, Mexico, and the Netherlands, his vaccine was licensed in the United States in 1961. It was favored over the Salk vaccine for its ability to induce strong intestinal immunity, ease of administration as a sugar cube or drops, and its capacity to create herd immunity by spreading attenuated virus in communities.

Later life and legacy

In his later years, he served as president of the Weizmann Institute of Science in Rehovot, Israel, and held distinguished positions at the National Institutes of Health and the Medical University of South Carolina. He was a vocal advocate for the use of his oral vaccine in global eradication efforts, which were spearheaded by the World Health Organization's Global Polio Eradication Initiative. His vaccine was instrumental in eliminating polio from the Americas and much of the world, though it was later phased out in some countries like the United States in favor of inactivated vaccines due to a small risk of vaccine-derived polio.

Awards and honors

His contributions to medicine were recognized with numerous prestigious awards. He received the National Medal of Science from President Richard Nixon in 1970. In 1986, President Ronald Reagan awarded him the Presidential Medal of Freedom, the nation's highest civilian honor. Other significant honors included the Feltrinelli Prize from the Accademia dei Lincei, the Albert Lasker Clinical Medical Research Award, and the Order of the Brilliant Star from the Republic of China. He was elected to the United States National Academy of Sciences and was a member of the American Academy of Arts and Sciences.

Category:American virologists Category:Polio researchers Category:Presidential Medal of Freedom recipients